已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab

医学 肝细胞癌 内科学 阿替唑单抗 贝伐单抗 肿瘤科 癌症 化疗 无容量 免疫疗法
作者
Atsushi Hiraoka,Takashi Kumada,Toshifumi Tada,Masashi Hirooka,Kazuya Kariyama,Joji Tani,Masanori Atsukawa,Koichi Takaguchi,Ei Itobayashi,Shinya Fukunishi,Kunihiko Tsuji,Toru Ishikawa,Kazuto Tajiri,Hironori Ochi,Satoshi Yasuda,Hidenori Toyoda,Chikara Ogawa,Takashi Nishimura,Takeshi Hatanaka,Satoru Kakizaki
出处
期刊:Hepatology Research [Wiley]
卷期号:53 (10): 1031-1042 被引量:16
标识
DOI:10.1111/hepr.13934
摘要

The present study focused on Geriatric Nutritional Risk Index (GNRI), which is based on bodyweight and serum albumin, and known as an easy-to-use nutritional assessment tool in clinical settings, to elucidate the prognostic predictive ability of GNRI in patients treated with atezolizumab plus bevacizumab (Atez/Bev) for hepatocellular carcinoma (HCC).A total of 525 HCC patients treated with Atez/Bev, based on their classification of unsuitable status for curative treatments and/or transarterial catheter chemoembolization, were enrolled (Child-Pugh A:B:C = 484:40:1, Barcelona Clinic Liver Cancer stage 0:A:B:C:D = 7:25:192:283:18). Prognosis was evaluated retrospectively using GNRI.Atez/Bev was used in 338 of the present cohort as first-line systemic chemotherapy (64.4%). Median progression-free survival based on GNRI indicating normal, mild decline, moderate decline, and severe decline was 8.3, 6.7, 5.3, and 2.4 months, respectively, whereas median overall survival was 21.4, 17.0, 11.5. and 7.3 months, respectively (both p < 0.001). The concordance index (c-index) values of GNRI for predicting prognosis (progression-free survival/overall survival) were superior to those of Child-Pugh class and albumin-bilirubin grade (0.574/0.632 vs. 0.527/0.570 vs. 0.565/0.629). As a subanalysis, muscle volume loss was observed in 37.5% of 256 patients with computed tomography data available. Along with GNRI decline, frequency of muscle volume loss became progressively larger (normal vs. mild vs. moderate vs. severe = 17.6% vs. 29.2% vs. 41.2% vs. 57.9%, p < 0.001), and a GNRI value of 97.8 was predictive of its occurrence (AUC 0.715, 95% CI 0.649-0.781; specificity/sensitivity = 0.644/0.688).These findings indicate that GNRI is an effective nutritional prognostic tool for predicting prognosis and muscle volume loss complication in HCC patients treated with Atez/Bev.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张aa发布了新的文献求助10
1秒前
ctomit发布了新的文献求助20
1秒前
噗宝凹发布了新的文献求助10
2秒前
包子凯越完成签到,获得积分10
3秒前
4秒前
白鹭立雪完成签到,获得积分10
12秒前
念初发布了新的文献求助10
13秒前
搜集达人应助fu采纳,获得10
15秒前
16秒前
快乐的小叮当应助噗宝凹采纳,获得10
16秒前
充电宝应助Chi_bio采纳,获得10
16秒前
粥粥应助碧蓝的宝马采纳,获得10
16秒前
柚又完成签到 ,获得积分10
19秒前
小王顶呱呱完成签到 ,获得积分10
19秒前
21秒前
21秒前
可知发布了新的文献求助10
22秒前
22秒前
23秒前
rhei发布了新的文献求助20
24秒前
氯化氟完成签到 ,获得积分20
24秒前
zydong完成签到,获得积分10
25秒前
詹卫卫发布了新的文献求助10
26秒前
i3utter发布了新的文献求助10
27秒前
28秒前
深情安青应助AOPs采纳,获得10
28秒前
六年发布了新的文献求助30
29秒前
Dorr发布了新的文献求助10
29秒前
打打应助氯化氟采纳,获得10
30秒前
隐形曼青应助念初采纳,获得10
30秒前
一直向前发布了新的文献求助10
30秒前
丘比特应助rhei采纳,获得30
32秒前
orixero应助洛芷采纳,获得10
34秒前
35秒前
丘比特应助多年以后采纳,获得10
35秒前
zhongu发布了新的文献求助10
35秒前
恋雅颖月应助晶晶采纳,获得10
37秒前
xiaoming发布了新的文献求助200
37秒前
38秒前
洛芷完成签到,获得积分10
39秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989918
求助须知:如何正确求助?哪些是违规求助? 3532013
关于积分的说明 11255831
捐赠科研通 3270829
什么是DOI,文献DOI怎么找? 1805053
邀请新用户注册赠送积分活动 882233
科研通“疑难数据库(出版商)”最低求助积分说明 809216